Popular Articles

Children's Hospitals And Clinics Of Minnesota Receive Level III Trauma Designation
The Minnesota Department of Health recently designated Children"s Hospitals and Clinics of Minnesota"s two hospital locations as Level III Trauma Hospitals. Children"s of Minnesota has the sixth busiest pediatric emergency department in the nation with over 84,000 visits per year, and already treats around 450 trauma cases each year. Children"s voluntarily participated in the intense designation process, which included an external review of the hospitals" res and capabilities to care for young trauma patients. Children"s met the required standards of commitment, clinical and equipment res, and staff training.

Judges Can Make Poor Decisions About Asylum Seekers
Judges often make poor decisions about the stories asylum seekers tell them because their decisions are based on false assumptions.
News of the day
The European Biotech Industry Applauds UK Efforts To Place Industrial Biotech At The Center Of A Low Carbon Economy
EuropaBio, the European biotech industry association applauds the report "IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy" (1) released today by the UK"s Department for Business Enterprise and Regulatory Reform (BERR). The biotech industry welcomes the report which is completely in line with the EU"s Lead Market Initiative for Biobased Products (2). EuropaBio is also pleased to note that the report also embraces EuropaBio"s policy recommendations (3) developed to help the EU realise the vision of a Knowledge-Based Bio-Economy (KBBE).
Medical Devices

MiR-196a Promotes The Metastases Of Tumors

MicroRNAs are small RNA molecules of 20-25 nucleotides length, regulating gene expression by inhibition of transcription or translation of proteins. High levels of miR-196a, a microRNA suppressing the expression of specific homebox genes that are of high relevance for the development of the human embryo, activated oncogenic pathways inside human tumor cells and induced tumor cell dissemination. miR-196a increased the chemosensitivity towards platin derivatives such as cisplatin and oxaliplatin and might be a useful biomarker. Analysing the microRNA expression pattern in pancreatic cancer by microRNA chip analyses, Carlo Croce found that 75% of tumours expressed miR-196a at a high level, predicting poor patient survival. Yekta and colleagues first described a miR-196a-directed cleavage of specific homebox genes (HoxB8, HoxC8, HoxD8 and HoxA7) in mouse embryos and mammalian cells. As a tumour-suppressive effect of HoxC8 has been previously discussed in humans, it has been hypothesized that miR-196a might promote tumour progression. A research article published on May 7, 2009 in the World Journal of Gastroenterology addresses this question. In fact, Carl Schimanski and colleagues report that miR-196a supports tumour cell detachment and tumour cell dissemination in vitro via activation of the AKT pathway. In order to confirm these experiments, they performed animal studies with immune suppressed mice which received a tail vein injection of human tumour cells. Pretreatment of tumour cells with miR-196a lead to significantly more lung metastases in these animals. Therefore, the authors conclude that miR-196a does support the development of metastases by exerting a pro-oncogenic function. Noteworthy, several other microRNA have been described that exert pro-oncogenic funtions, such as miR-17-92 which is significantly increased in small-cell lung cancer and decreases survival by inhibition of tumour-suppressor genes PTEN and RB2. The exact mode of function of miR-196a still needs to be analysed. Reference: Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M, Gockel I. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 2009; 15(17): 2089-2096 http://www.wjgnet.com/1007-9327/15/2089.asp Correspondence to: Carl Christoph Schimanski, First Department of Internal Medicine, Johannes Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. Lin Tian World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):